B+
Bull case
30%
Probability
Target price
$130.00
+47.2% vs current
HQY
HealthEquityBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
50%
Probability
Target price
$114.40
+29.5% vs current
B-
Bear case
20%
Probability
Target price
$79.00
-10.6% vs current
AI sentiment snapshot
Latest data as of 2026-05-29
Recent news sentiment (30D)
-26.5
Negative
Company
-
Unavailable
Macro
-26.5
Negative
Pulse
-
Unavailable
Sentiment proxy
+76.0
Score
AI commentary
Post-earnings tone is positive because the company beat estimates, raised FY2027 guidance, and the shares rose 3.9% after hours; however, the checked sources did not yet show a clear post-print analyst revision wave, so this remains a monitoring view rather than a fully confirmed re-rate.
RankAlpha Sentiment Codex - 2026-05-29
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-29eventQ1 beat and FY2027 guide raiseMedium impact
HealthEquity reported Q1 revenue of $354.6M and non-GAAP EPS of $1.24 versus $1.11 consensus, then raised FY2027 revenue guidance to $1.410B-$1.420B and Adjusted EBITDA to $625M-$633M while authorizing an additional $1.0B of repurchases [#8-K-2026-05-28].
2026-05-29catalystPost-print tape stays constructiveMedium impact
Trusted market coverage said the shares were up 3.9% in after-hours trading after the beat-and-raise print, but the post-earnings analyst revision set was still thin in the sources checked.
2026-08-31catalystHSA assets and accounts keep compoundingHigh impact
HSAs reached 10.6M (+8% y/y) and total HSA assets reached $37.1B (+19% y/y), supporting a longer-run operating leverage case as the member base deepens and the asset mix shifts toward investments [#8-K-2026-05-28].
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-29 • Updated nightlySource: Internal modelMethodology